HRSA did not approve J&J's newly proposed 340B rebate model, an agency spokesperson told 340B Report.

HRSA Says Johnson & Johnson’s New 340B Rebate Model Did Not Receive Agency Approval, Is ‘Inconsistent’ with 340B Statute

August 23, 2024 William Newton, Associate Editor/Senior Writer Views

The federal agency that oversees the 340B program did not approve drugmaker Johnson & Johnson’s (J&J’s) proposal to convert certain [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!